AP2000001907A0 - Crystalline form of paroxetine. - Google Patents
Crystalline form of paroxetine.Info
- Publication number
- AP2000001907A0 AP2000001907A0 APAP/P/2000/001907A AP2000001907A AP2000001907A0 AP 2000001907 A0 AP2000001907 A0 AP 2000001907A0 AP 2000001907 A AP2000001907 A AP 2000001907A AP 2000001907 A0 AP2000001907 A0 AP 2000001907A0
- Authority
- AP
- ARIPO
- Prior art keywords
- paroxetine
- crystalline form
- free
- therapy
- pure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2000001907A0 true AP2000001907A0 (en) | 2000-09-30 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2000/001907A AP2000001907A0 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (xx) |
| JP (1) | JP2002506865A (xx) |
| KR (1) | KR20010041947A (xx) |
| CN (1) | CN1300286A (xx) |
| AP (1) | AP2000001907A0 (xx) |
| AU (1) | AU2847199A (xx) |
| BG (1) | BG104839A (xx) |
| BR (1) | BR9908825A (xx) |
| CA (1) | CA2323896A1 (xx) |
| EA (1) | EA200000946A1 (xx) |
| HU (1) | HUP0101215A3 (xx) |
| ID (1) | ID27596A (xx) |
| IL (1) | IL138390A0 (xx) |
| NO (1) | NO20004583L (xx) |
| PL (1) | PL342931A1 (xx) |
| SK (1) | SK13622000A3 (xx) |
| TR (1) | TR200002675T2 (xx) |
| WO (1) | WO1999047519A1 (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
-
1999
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG104839A (en) | 2001-09-28 |
| JP2002506865A (ja) | 2002-03-05 |
| PL342931A1 (en) | 2001-07-16 |
| ID27596A (id) | 2001-04-12 |
| NO20004583D0 (no) | 2000-09-14 |
| NO20004583L (no) | 2000-09-15 |
| HUP0101215A3 (en) | 2002-05-28 |
| EP1064282A1 (en) | 2001-01-03 |
| TR200002675T2 (tr) | 2000-12-21 |
| CN1300286A (zh) | 2001-06-20 |
| BR9908825A (pt) | 2000-11-21 |
| CA2323896A1 (en) | 1999-09-23 |
| WO1999047519A1 (en) | 1999-09-23 |
| HUP0101215A2 (hu) | 2002-04-29 |
| IL138390A0 (en) | 2001-10-31 |
| EA200000946A1 (ru) | 2001-02-26 |
| AU2847199A (en) | 1999-10-11 |
| KR20010041947A (ko) | 2001-05-25 |
| SK13622000A3 (sk) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| HU9503605D0 (en) | Use of nona- and decapeptides in the preparation of a drug for the treatment of aids | |
| MY114014A (en) | Imidazole compounds, compositions and use | |
| AP2001002225A0 (en) | 1-heterocycle substituted diarylamines. | |
| EP0900083A4 (en) | NEW SUBSTITUTED IMIDAZOLES | |
| MX9805634A (es) | Compuestos novedosos de imidazol substituido. | |
| GEP20033092B (en) | Purine Inhibitors of Cyclin Dependent Kinase 2 and Ik-Aa | |
| SI0882021T1 (en) | New phenanthridines | |
| PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
| MY122383A (en) | Cyclic boroproline compounds | |
| BR0010220A (pt) | Compostos de pirimidinona | |
| MY122391A (en) | Piperazine derivatives as 5-ht1b antagonists | |
| HK1029922A1 (en) | Angiostatic agents and compositions for treating glc1a glaucoma | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| AU2838101A (en) | Use of melatonin for treating androgenetic and diffuse alopecia | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| MXPA04004503A (es) | Derivados de piperina y su uso como moduladores de actividad receptora de quimiocina (especialmente ccr5). | |
| SE9802208D0 (sv) | Novel compounds | |
| PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
| CA2418167A1 (en) | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses | |
| IL135825A0 (en) | Use of mirtazapine for treating sleep apneas | |
| PL356780A1 (en) | Novel compounds | |
| HK1029944A1 (en) | Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway | |
| TR200403001T3 (tr) | Lovastatin ve simvastatinin, azaltılmış dimerik katışkı seviyelerine sahip olacak şekilde arıtılması için bir işlem | |
| AP2000001907A0 (en) | Crystalline form of paroxetine. |